COMMUNIQUÉS West-GlobeNewswire

VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
03/03/2026
Veteran business development leader with deep expertise in human-relevant NAM and spheroid-based in vitro services to spearhead commercial growth along the US East Coast, deepening VivoSim’s reach with biopharma [...]
Fort Wayne Rheumatologists Monica Reddy, Karen Ringwald and Anil Rao Open Fort Wayne Rheumatology and Infusion
03/03/2026
FORT WAYNE, Ind., March 03, 2026 (GLOBE NEWSWIRE) -- Fort Wayne Rheumatology and Infusion is now open and serving patients at 7910 W. Jefferson Blvd., Suite 217, in Fort Wayne. The new practice is led by Board-certified [...]
Immix Biopharma to Participate in Upcoming Investor Conferences
03/03/2026
LOS ANGELES, CA, March 03, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present [...]
Journal of Analytical Toxicology Publishes Peer-Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories’ Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies’ Breath Collection Unit
03/03/2026
VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories Inc (“Omega”) proudly announce [...]
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
03/03/2026
MINNEAPOLIS, March 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
03/03/2026
Randomized, placebo-controlled study to evaluate safety, tolerability, and potential for positive impact on lung function AUSTIN, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a [...]
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
03/03/2026
GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026. Mr. Fowler brings [...]
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
03/03/2026
NEW HOPE, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through [...]
TOMI Environmental Solutions Appoints Total Clean Air as Preferred European Partner for SteraMist iHP Decontamination Technology
03/03/2026
Strategic Partnership Strengthens UK and EU GMP Annex 1 Compliance FREDERICK, Md., March 03, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and [...]
Prolium Bioscience Launches with $50 Million and Announces First Patients Dosed with PRO-203, a Potential Best-in-Class CD20xCD3 T-Cell Engager, for Severe Autoimmune Disease
03/03/2026
Initial $50M Series A investment from founding investor RTW Investments Proceeds will fund clinical development of PRO-203 in systemic sclerosis (SSc) and multiple additional severe autoimmune diseases NEW YORK, March [...]
NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion
03/03/2026
ATHENS, Ga., March 03, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP) (“Company”), a pioneer in eco-friendly biosafety and health solutions, announces a significant strengthening of its e-commerce [...]
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
03/03/2026
– Paris Hilton shares her personal ADHD journey and encourages others to see ADHD in a new light – – Together, Paris and Collegium are reframing common stereotypes and highlighting experiences that are often part of [...]
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
03/03/2026
Oak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders filed in its [...]
Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in Potential Royalties and Milestones upon execution of a Definitive Agreement
03/03/2026
The Collaboration Framework marks Adial’s first step towards commercial partnership and establishing an exclusive European pathway as AD04 advances toward pivotal Phase 3 development GLEN ALLEN, Va., March 03, 2026 ( [...]
Opus Genetics to Present at Upcoming Investor Conferences in March 2026
03/03/2026
RESEARCH TRIANGLE PARK, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc . (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
03/03/2026
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. RADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a [...]
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
03/03/2026
-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing engagement with FDA for PM359 in CGD; plan to [...]
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
03/03/2026
EMERYVILLE, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today [...]
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
03/03/2026
- Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation SAN FRANCISCO and BERLIN, March 03, 2026 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a [...]

Pages